YCM
Yiheng Capital Management Portfolio holdings
AUM
$276M
This Quarter Return
+2.37%
1 Year Return
+10.95%
3 Year Return
+44.87%
5 Year Return
+78.88%
10 Year Return
–
AUM
$1.28B
AUM Growth
+$1.28B
(-0.51%)
Cap. Flow
+$3.12M
Cap. Flow
% of AUM
0.24%
Top 10 Holdings %
Top 10 Hldgs %
79.24%
Holding
29
New
3
Increased
4
Reduced
6
Closed
–
Top Buys
| 1 |
Roblox
RBLX
|
$45.4M |
| 2 |
indie Semiconductor
INDI
|
$24.9M |
| 3 |
Keros Therapeutics
KROS
|
$23.7M |
| 4 |
Viridian Therapeutics
VRDN
|
$6.75M |
| 5 |
TAL Education Group
TAL
|
$4.91M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$35.8M |
| 2 |
HIMX
Himax Technologies
HIMX
|
$32M |
| 3 |
New Oriental
EDU
|
$19.3M |
| 4 |
Akero Therapeutics
AKRO
|
$13.1M |
| 5 |
TransDigm Group
TDG
|
$4.64M |
Sector Composition
| 1 | Communication Services | 24.54% |
| 2 | Consumer Discretionary | 17.79% |
| 3 | Healthcare | 15.92% |
| 4 | Consumer Staples | 11.77% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bilibili
BILI
$9.6B
| $265M | 10.47% | 11,270,198 -180,819 | -2% | -$4.25M |
|
2
Huazhu Hotels Group
HTHT
$11.3B
| $136M | 5.39% | 2,783,620 | – | – |
|
|
3
New Oriental
EDU
$7.85B
| $133M | 5.26% | 3,442,666 -499,706 | -13% | -$19.3M |
|
|
NOAH
4
Noah Holdings
NOAH
$824M
| $104M | 4.12% | 6,719,722 | – | – |
|
5
JD.com
JD
$44.1B
| $86.5M | 3.42% | 1,971,740 +111,300 | +6% | +$4.88M |
|
|
6
TransDigm Group
TDG
$78.8B
| $74.7M | 2.95% | 101,312 -6,300 | -6% | -$4.64M |
|
|
HOLI
7
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $68.7M | 2.72% | 3,963,836 | – | – |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $52.2M | 2.06% | 2,143,497 -1,469,757 | -41% | -$35.8M |
|
|
PENG
9
Penguin Solutions, Inc. Ordinary Shares
PENG
$1.26B
| $50.9M | 2.01% | 2,953,992 | – | – |
|
|
10
Roblox
RBLX
$86.4B
| $45.4M | 1.79% | +1,008,274 | New | +$45.4M |
|
11
Sabre
SABR
$706M
| $44.7M | 1.77% | 10,421,742 | – | – |
|
|
12
Akero Therapeutics
AKRO
$3.74B
| $43.1M | 1.7% | 1,125,791 -343,114 | -23% | -$13.1M |
|
|
13
Viridian Therapeutics
VRDN
$1.5B
| $31.3M | 1.24% | 1,228,534 +265,278 | +28% | +$6.75M |
|
|
14
indie Semiconductor
INDI
$899M
| $24.9M | 0.98% | +2,360,221 | New | +$24.9M |
|
|
15
Keros Therapeutics
KROS
$618M
| $23.7M | 0.94% | +554,151 | New | +$23.7M |
|
16
Denali Therapeutics
DNLI
$2.23B
| $23.4M | 0.92% | 1,014,684 | – | – |
|
|
17
TAL Education Group
TAL
$6.46B
| $18.1M | 0.71% | 2,818,300 +765,900 | +37% | +$4.91M |
|
18
Beam Therapeutics
BEAM
$1.66B
| $14.2M | 0.56% | 463,800 | – | – |
|
|
HIMX
19
Himax Technologies
HIMX
$1.42B
| $9.64M | 0.38% | 1,185,814 -3,941,902 | -77% | -$32M |
|
|
IVA
20
Inventiva
IVA
$861M
| $9.63M | 0.38% | 2,644,926 | – | – |
|
21
Generation Bio
GBIO
$40.4M
| $6.89M | 0.27% | 1,601,766 +415,471 | +35% | +$1.79M |
|
|
NIU
22
Niu Technologies
NIU
$341M
| $4.81M | 0.19% | 1,162,675 | – | – |
|
|
ZH
23
Zhihu
ZH
$421M
| $4.6M | 0.18% | 3,618,353 | – | – |
|
24
ACM Research
ACMR
$1.81B
| $3.54M | 0.14% | 302,300 | – | – |
|
25
CommScope
COMM
$3.55B
| $1.27M | 0.05% | 200,004 | – | – |
|